Vaccine for the treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2730048

The invention provides a method for the treatment of a patient having a more severe form of Alzheimer's disease (AD), where the severe form of AD is characterized by pathogenic deposits of amyloid beta peptide (A.beta.), comprising the administration of an immunogenic fragment of A.beta. capable of inducing an immune response in the form of antibodies to specific to the pathogenic deposits of A.beta. and, in particular, to neurotoxic forms of A.beta. including N-terminally truncated forms of A.beta.. The invention further provides a method for selecting a suitable immunogenic fragment of A.beta. for the treatment of a more severe form of AD.

La présente invention concerne un procédé pour le traitement dun patient présentant une forme plus grave de la maladie dAlzheimer (MA), la forme grave de MA étant caractérisée par des dépôts pathogènes du peptide bêta-amyloïde (Aß), consistant en ladministration dun fragment immunogène de Aß pouvant induire une réponse immunitaire sous la forme danticorps dirigés spécifiquement contre les dépôts pathogènes de Aß et, en particulier, contre les formes neurotoxiques de Aß comprenant les formes de Aß tronquées en N-terminal. Linvention concerne en outre un procédé permettant de sélectionner un fragment immunogène de Aß approprié pour le traitement dune forme plus grave de MA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccine for the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine for the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1699557

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.